This proposal seeks to answer fundamental questions about cytoskeletal filaments, which are central regulators of cell biology. Our current understanding of bacteria is that these organisms use dynamic cytoskeletal systems to organize and regulate essential cellular processes. The results of our previous HFSP grant broke new ground by demonstrating that the number of these systems extends beyond homologs of the three primary eukaryotic cytoskeletons (i.e., actin, tubulin, and intermediate filaments). Two representative examples are our discovery of bactofilins, which are a bacteria-specific family of proteins, and of CTP synthase, an enzyme that is widely conserved across all kingdoms of life. These cytoskeletal proteins play key roles in regulating cell shape, metabolism, and intracellular compartmentalization, and their identification has had a transformative impact on the field of bacterial cell biology.
Building on our successful previous approaches, our renewal proposal is designed to characterize these novel cytoskeletons and, in addition, identify new cytoskeletal proteins. Apart from using a wide range of genetic, biochemical, and biophysical techniques, a central theme in this proposal is the identification, characterization, and application of small molecules to analyze protein function in vivo and in vitro. Small molecules can be powerful tools for studying bacterial and eukaryotic cytoskeletons, as they enable the rapid perturbation of protein function in vivo. Nevertheless, only few small molecules are currently available for specifically targeting cytoskeletal elements in bacteria. The discovery of chemical probes is poised to further our understanding of bacterial cell biology, while new classes of small molecules that emerge from these studies may provide starting points for developing new classes of antibacterial agents. Compounds that regulate widely conserved proteins may also inspire the development of therapeutic compounds for cancer and immune research and treatment.
In the first three years of the HFSP grant, we established a successful formula for productive collaboration between our labs. For the renewal, we have modified this formula to match the goals of the next phase of this project by focusing the expertise and capabilities of an interdisciplinary group of young scientists: Zemer Gitai uses high-throughput methods to study the bacterial cytoskeleton, Justin Kollman uses electron microscopy to study the biophysics of cytoskeletal assembly, Martin Thanbichler studies the biochemistry and genetics of the bacterial cytoskeleton, and Doug Weibel uses chemistry and engineering to study bacterial physiology. The salient features of this collaborative and interdisciplinary project will facilitate intellectual and cultural cross-pollination, and the scope and high-risk-high-reward merit of this proposal are designed specifically for an international funding mechanism such as the HFSP.